PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 142 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.3%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 2,449,183 | $43,400,000 | 3.81% |
BVF INC/IL | 3,901,759 | $69,139,000 | 2.70% |
COMMODORE CAPITAL LP | 498,079 | $8,826,000 | 2.33% |
Altium Capital Management LP | 346,000 | $6,131,000 | 1.61% |
Twin Lakes Capital Management, LLC | 139,287 | $2,468,000 | 1.45% |
Opaleye Management Inc. | 330,222 | $5,852,000 | 1.09% |
EcoR1 Capital, LLC | 1,443,800 | $25,584,000 | 0.89% |
OBERMEYER WOOD INVESTMENT COUNSEL, LLLP | 776,689 | $13,763,000 | 0.76% |
JABODON PT CO | 90,656 | $1,606,000 | 0.66% |
Artal Group S.A. | 1,500,000 | $26,580,000 | 0.60% |